Dr. Velenosi received his PhD in pharmacology and toxicology from Western University. As a graduate student, he used state-of-the-art metabolomics analysis to identify a novel metabolic biomarker of kidney function in patients with chronic kidney disease. He then joined the Laboratory of Metabolism at the National Cancer Institute (National Institutes of Health) as a postdoctoral fellow, which was supported by the Canadian Institutes of Health Research Fellowship. There, he began his research vision by developing a novel approach to using metabolic biomarkers as a path for personalizing therapy and improving outcomes for cancer patients. He is currently an assistant professor in the UBC Faculty of Pharmaceutical Sciences.